Frost Phillip MD Et Al's Form 4 filing
Opko Health, Inc. (OPK) · filed Nov 18, 2025
- Accession no.
- 0001193125-25-286448
- Filed
- Nov 18, 2025, 5:18 PM ET
- Trade date
- Nov 18, 2025
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 12 non-derivative transactions and 0 derivative transactions. Open-market purchases total $678.9K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Frost Phillip MD Et AlCIK 0000898860 | Director, Officer (CEO & Chairman), 10% Owner |
| Frost Gamma Investments TrustCIK 0001380896 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +410 | $1.25 | +$510.45 | 214,386,858 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +49,590 | $1.25 | +$61,987.5 | 214,436,448 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +66,635 | $1.26 | +$83,626.93 | 214,503,083 | Indirect | |
| Nov 18, 2025 | Common Stock | AGrant or awardAcquired | +46,700 | $1.26 | +$58,842 | 214,549,783 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +15,000 | $1.27 | +$18,975 | 214,564,783 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +1,772 | $1.27 | +$2,250.44 | 214,566,555 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +212,608 | $1.28 | +$271,075.2 | 214,779,163 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +69,728 | $1.28 | +$89,251.84 | 214,848,891 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +428 | $1.28 | +$549.85 | 214,849,319 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +83,556 | $1.29 | +$107,369.46 | 214,932,875 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +1 | $1.29 | +$1.29 | 214,932,876 | Indirect | |
| Nov 18, 2025 | Common Stock | PPurchaseAcquired | +33,572 | $1.29 | +$43,307.88 | 214,966,448 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.